+199.7%
SNDK vs EMR
+11.4%
+188.3%
-56.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.5% | -1.2% | +2.7% | +3.1% |
| 7D | +13.6% | +0.9% | +12.7% | +12.4% |
| 30D | +42.5% | -5.0% | +47.5% | +52.2% |
| 3M | +7.1% | +5.9% | +1.2% | +0.3% |
| 6M | +199.7% | +7.3% | +192.3% | +180.6% |
| All | +199.7% | +11.4% | +188.3% | +180.6% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling